Skip to main content

Assessment of Aortic Stenosis


 Assessment of Aortic Stenosis



---

Introduction

Aortic stenosis (AS) is the most common valvular heart disease requiring intervention in adults. It results from progressive narrowing of the aortic valve opening, leading to obstruction of left ventricular outflow. This increases left ventricular pressure, causes compensatory hypertrophy, and eventually results in heart failure, syncope, or sudden cardiac death if untreated.

Accurate assessment of aortic stenosis is essential for determining disease severity, timing of intervention, and prognosis. Echocardiography remains the cornerstone of evaluation, supported by clinical assessment and additional imaging when required.


---

Etiology of Aortic Stenosis

The major causes include:

Degenerative (Calcific) Aortic Stenosis
Most common cause in elderly patients due to progressive calcification of the valve.

Bicuspid Aortic Valve
Congenital abnormality leading to earlier valve degeneration.

Rheumatic Heart Disease
Leads to leaflet thickening, fusion, and calcification.

Less common causes include radiation-induced valve disease and congenital unicuspid valves.


---

Clinical Assessment

Symptoms are critical in determining management.

Classic triad of symptomatic severe AS includes:

Angina
Due to increased myocardial oxygen demand and reduced coronary perfusion.

Syncope
Occurs during exertion due to fixed cardiac output.

Dyspnea
Results from elevated LV filling pressures and heart failure.

Other findings may include fatigue, reduced exercise tolerance, and palpitations.

Physical Examination

Important signs include:

Slow rising carotid pulse (pulsus parvus et tardus)

Harsh ejection systolic murmur best heard at the right upper sternal border

Radiation of murmur to carotid arteries

Soft or absent second heart sound in severe disease

Presence of an S4 due to left ventricular hypertrophy


---

Role of Echocardiography

Transthoracic echocardiography (TTE) is the primary diagnostic tool for assessing aortic stenosis.

It provides information about:

Valve morphology
Valve calcification
Severity of stenosis
Left ventricular function
Associated valve disease


---

Key Echocardiographic Parameters

Severity of AS is determined using three major parameters.

Peak Aortic Jet Velocity

Measured using continuous wave Doppler across the aortic valve.

Mild AS
2.6 – 2.9 m/s

Moderate AS
3.0 – 3.9 m/s

Severe AS
≥ 4.0 m/s


---

Mean Transvalvular Gradient

Calculated from Doppler velocities using the Bernoulli equation.

Mild
< 20 mmHg

Moderate
20 – 39 mmHg

Severe
≥ 40 mmHg


---

Aortic Valve Area (AVA)

Calculated using the continuity equation.

Normal AVA
3 – 4 cm²

Severe AS
≤ 1.0 cm²

Very severe AS
≤ 0.6 cm²

Indexed AVA ≤ 0.6 cm²/m² also suggests severe stenosis.


---

Continuity Equation

The continuity equation is based on the principle of conservation of flow.

Flow through the LVOT equals flow through the aortic valve.

AVA = (LVOT area × LVOT VTI) / AV VTI

Where

LVOT area = Ο€ (LVOT diameter/2)²

This is the most reliable method for calculating valve area.


---

Low-Flow Low-Gradient Aortic Stenosis

Some patients may have severe AS with lower gradients.

Types

Classical Low Flow Low Gradient
Reduced EF (<50%)

Paradoxical Low Flow Low Gradient
Preserved EF but reduced stroke volume index (<35 ml/m²)

Dobutamine stress echocardiography helps differentiate:

True severe AS
Pseudo severe AS


---

Dimensionless Index

Also known as the Doppler Velocity Index.

DVI = LVOT VTI / Aortic Valve VTI

Interpretation

DVI > 0.50 → Mild AS
DVI 0.25 – 0.50 → Moderate AS
DVI < 0.25 → Severe AS

This parameter is useful when LVOT measurement is uncertain.


---

Additional Imaging Modalities

CT Aortic Valve Calcium Scoring

Useful when echo findings are discordant.

Severe AS likely when calcium score exceeds:

Men

> 2000 Agatston units



Women

> 1200 Agatston units




---

Cardiac MRI

Helpful for:

Assessing LV function
Evaluating myocardial fibrosis
Assessing flow when echo images are poor


---

Cardiac Catheterization

Now rarely required for diagnosis.

Indications include:

Discordant non-invasive findings
Evaluation before valve surgery
Assessment of coronary artery disease


---

Staging of Aortic Stenosis

According to ACC/AHA guidelines:

Stage A
At risk (bicuspid valve or sclerosis)

Stage B
Progressive mild-moderate AS

Stage C
Severe AS but asymptomatic

Stage D
Symptomatic severe AS


---

Follow-Up Recommendations

Mild AS
Echo every 3–5 years

Moderate AS
Echo every 1–2 years

Severe AS
Echo every 6–12 months


---

When to Consider Intervention

Intervention is indicated in:

Symptomatic severe AS

Severe AS with LV dysfunction (EF <50%)

Severe AS undergoing other cardiac surgery

Very severe AS with abnormal exercise test

Options include surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI).


---

Key Takeaways

Aortic stenosis is a progressive disease that requires careful clinical and echocardiographic assessment.

Peak velocity, mean gradient, and valve area are the primary parameters used to determine severity.

Low-flow states can mask severe disease and require advanced evaluation.

Timely recognition of severe AS is essential because once symptoms develop, prognosis without intervention is poor.


---

drmusmanjaved.com

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...